Clinical implications of anti-idiotype antibodies in COVID-19.

MLA

Shukla, Ajay Kumar, and Saurav Misra. “Clinical Implications of Anti-Idiotype Antibodies in COVID-19.” Journal of Basic & Clinical Physiology & Pharmacology, vol. 33, no. 6, Nov. 2022, pp. 727–33. EBSCOhost, https://doi.org/10.1515/jbcpp-2022-0123.

APA

Shukla, A. K., & Misra, S. (2022). Clinical implications of anti-idiotype antibodies in COVID-19. Journal of Basic & Clinical Physiology & Pharmacology, 33(6), 727–733. https://doi.org/10.1515/jbcpp-2022-0123

Chicago

Shukla, Ajay Kumar, and Saurav Misra. 2022. “Clinical Implications of Anti-Idiotype Antibodies in COVID-19.” Journal of Basic & Clinical Physiology & Pharmacology 33 (6): 727–33. doi:10.1515/jbcpp-2022-0123.